IPCA Laboratories Limited (IPCALAB) Stock Statistics & Valuation Metrics

IPCA Laboratories Limited has a market cap or net worth of ₹373.07B. The enterprise value is ₹383.36B.

IPCA Laboratories Limited has 253,704,220 shares outstanding. The number of shares has decreased by -2.65% in one year.

IPCA Laboratories Limited’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 9.12%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, IPCA Laboratories Limited had revenue of 89.40B and earned 7.38B in profits. Earnings per share was 29.07.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

IPCA Laboratories Limited pays an annual dividend of ₹4, resulting in a dividend yield of 0.54%

IPCA Laboratories Limited upcoming earnings date is Aug 19, 2025, TBA (Confirmed).

IPCA Laboratories Limited as a current ratio of 2.50, with Debt / Equity ratio of 19.61%

In the past 12 months, IPCA Laboratories Limited has paid 3.44B in taxes.

IPCA Laboratories Limited EV to EBITDA ratio is 0.63, with an EV/FCF ratio of 2.04.

IPCA Laboratories Limited has ₹9.03B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -₹9.03B billion.

Gross margin is 62.20%, with operating margin of 14.86%, and net profit margin of 8.25%.

The average price target for IPCA Laboratories Limited is ₹1,435.00, which is 11.43% higher than the current price. The consensus rating is Hold